Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Ayako Urabe"'
Autor:
Naoki Morishita, Ryotaro Sakamori, Tomomi Yamada, Yugo Kai, Yuki Tahata, Ayako Urabe, Ryoko Yamada, Takahiro Kodama, Hayato Hikita, Yoshinori Doi, Shinji Tamura, Hideki Hagiwara, Yasuharu Imai, Sadaharu Iio, Tomohide Tatsumi, Tetsuo Takehara
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234811 (2020)
BackgroundL31 and Y93 in the NS5A region of the hepatitis C virus (HCV) are the most important substitution positions associated with resistance to direct-acting antiviral (DAA) treatment.MethodsWe analyzed the frequency of NS5A L31M/V and Y93/H in N
Externí odkaz:
https://doaj.org/article/03a404d7bb3c41b0931f68b59b9a944e
Autor:
Yuki Tahata, Ryotaro Sakamori, Ayako Urabe, Naoki Morishita, Ryoko Yamada, Takayuki Yakushijin, Naoki Hiramatsu, Yoshinori Doi, Akira Kaneko, Hideki Hagiwara, Yukinori Yamada, Taizo Hijioka, Masami Inada, Shinji Tamura, Yasuharu Imai, Kunimaro Furuta, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Publikováno v:
Hepatology Communications, Vol 2, Iss 8, Pp 888-896 (2018)
Combination treatment of ledipasvir and sofosbuvir (LDV/SOF) is first‐line treatment for patients with chronic hepatitis C genotype 1 in the United States, Europe, and Japan. However, the influence of LDV/SOF on the cardiovascular system is poorly
Externí odkaz:
https://doaj.org/article/6628cfc9760b49e591fb8bc5c0f501b9
Autor:
Noriyuki Konishi, Hajime Kumagai, Hiroyuki Sawatari, Tetsuro Hoshino, Yoko Murase, Maiko Yamaguchi, Ayako Urabe, Yuka Kiyohara, Aki Arita, Masayo Baku, Ryujiro Sasanabe, Toshiaki Shiomi
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 12; Pages: 3271
School non-attendance due to difficulties waking up is increasing in Japan, and affected students are commonly diagnosed with orthostatic dysregulation (OD); however, OD-associated sleep problems are overlooked. To date, no sleep-medicine-based treat
Autor:
Ritsuo Mouri, Yoshiki Hatsushika, Takayuki Fukuhara, Keiji Tsuji, Nami Mori, Eisuke Miyaki, Tomohiko Kohno, Yumiko Yamashita, Akihito Okazaki, Hidenori Ochi, Ayaka Sakano, Yoshinari Furukawa, Ayako Urabe, Hideharu Okanobu, Shintaro Takaki
Publikováno v:
Esophagus. 18:669-675
The study aimed to investigate the efficacy of vonoprazan 10 mg compared with 20 mg in patients with erosive esophagitis. Seventy-three patients with erosive esophagitis were randomly divided into two groups either vonoprazan 20 mg (n = 37) or 10 mg
Autor:
Sadaharu Iio, Tomohide Tatsumi, Eiji Mita, Ayako Urabe, Ryoko Yamada, Kazuyoshi Ohkawa, Tetsuo Takehara, Toshifumi Ito, Takayuki Yakushijin, Hayato Hikita, Ryotaro Sakamori, Kazuki Maesaka, Masahide Oshita, Shinji Tamura, Yuki Tahata, Takahiro Kodama, Hideki Hagiwara
Publikováno v:
Hepatology Research. 50:1091-1100
Aim Preserved liver function may be an important factor affecting therapeutic efficacy in hepatocellular carcinoma patients treated with lenvatinib, but not all patients can be treated while preserving liver function. This study evaluated the therape
Autor:
Hajime Kumagai, Hiroyuki Sawatari, Tetsuro Hoshino, Noriyuki Konishi, Yuka Kiyohara, Kengo Kawaguchi, Yoko Murase, Ayako Urabe, Aki Arita, Toshiaki Shiomi
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 19; Issue 16; Pages: 9906
Purpose: Continuous positive airway pressure (CPAP) therapy is a well-established treatment for obstructive sleep apnea (OSA). In this study, we aimed to assess the effects of CPAP therapy on nocturnal blood pressure (NBP) fluctuations (NBPFs) during
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69355aaf84e007a19f3295d11d014860
https://doi.org/10.21203/rs.3.rs-1333398/v1
https://doi.org/10.21203/rs.3.rs-1333398/v1
Autor:
Takayuki Yakushijin, Hiroyuki Fukui, Masami Inada, Yoshiaki Inui, Masahide Oshita, Hayato Hikita, Naoki Morishita, Naoki Hiramatsu, Shinji Tamura, Tetsuo Takehara, Ayako Urabe, Eiji Mita, Ryoko Yamada, Atsuo Inoue, Tsugiko Oze, Taizo Hijioka, Kazuhiro Katayama, Yuki Tahata, Ryotaro Sakamori, Tomohide Tatsumi, Yasuharu Imai, Toshimitsu Hamasaki, Akira Yamada, Takahiro Kodama, Toshifumi Itoh, Norio Hayashi, Hideki Hagiwara
Publikováno v:
Hepatology Research. 49:570-578
Aim In patients with chronic hepatitis C, hepatocellular carcinoma (HCC) occurs at a certain frequency, even if a sustained virologic response (SVR) is achieved by antiviral treatment. Old age, liver fibrosis, and high post-treatment α-fetoprotein (
Autor:
Takahiro Kodama, Masahide Oshita, Hideki Hagiwara, Ayako Urabe, Yuki Tahata, Ryoko Yamada, Yasuharu Imai, Ryotaro Sakamori, Tetsuo Takehara, Tomohide Tatsumi, Hayato Hikita, Kazuyoshi Ohkawa, Naoki Hiramatsu
Publikováno v:
Hepatology research : the official journal of the Japan Society of HepatologyREFERENCES. 50(10)
Aim It remains unclear how direct-acting antiviral (DAA) treatments influence hepatocellular carcinoma (HCC) recurrence and survival in comparison with interferon (IFN). Methods In total, 338 patients with chronic hepatitis C virus (HCV) infection an
Autor:
Chihiro Kato, Yoko Haseda, Tetsuro Hoshino, Noriyuki Konishi, Reiko Hori, Masayo Baku, Ayako Urabe, Toshiaki Shiomi, Masato Imai, Atsuhiko Nomura, Kohta Suzuki, Aki Arita, Mamiko Mano, Maiko Yamaguchi, Ryujiro Sasanabe
Publikováno v:
Biomedical Journal of Scientific & Technical Research. 24
School attendance is essential for both academic and socialemotional development. However, increasing numbers of teenagers visit our sleep clinic because of school absenteeism caused by difficulty getting up or excessive morning sleepiness..
Autor:
Yasuharu Imai, Takayuki Yakushijin, Masami Inada, Takahiro Kodama, Ryoko Yamada, Ayako Urabe, Hayato Hikita, Naoki Morishita, Yoshinori Doi, Tetsuo Takehara, Shinji Tamura, Kunimaro Furuta, Ryotaro Sakamori, Yukinori Yamada, Tomohide Tatsumi, Hideki Hagiwara, Akira Kaneko, Taizo Hijioka, Naoki Hiramatsu, Yuki Tahata
Publikováno v:
Hepatology Communications
Hepatology Communications, Vol 2, Iss 8, Pp 888-896 (2018)
Hepatology Communications, Vol 2, Iss 8, Pp 888-896 (2018)
Combination treatment of ledipasvir and sofosbuvir (LDV/SOF) is first-line treatment for patients with chronic hepatitis C genotype 1 in the United States, Europe, and Japan. However, the influence of LDV/SOF on the cardiovascular system is poorly ch